Lawrence Klein - Mar 21, 2022 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Director
Signature
/s/ Jeet Mahal, as Attorney-in-Fact
Stock symbol
JSPR
Transactions as of
Mar 21, 2022
Transactions value $
$0
Form type
4
Date filed
3/23/2022, 06:05 PM
Previous filing
Mar 14, 2022
Next filing
Jun 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Award $0 +78K $0.00 78K Mar 21, 2022 Voting Common Stock 78K $3.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3rd of the shares subject to the option shall vest on December 7, 2022, and 1/3rd of the shares subject to the option shall vest on each anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.